Market Overview

UPDATE: Credit Suisse Raises PT on AmerisourceBergen Corp. on Multi-Year Growth Outlook

Share:
Related ABC
AmerisourceBergen Is 'The Pony To Ride' For Biosimilars
Citi: 'Size Matters' For Independent Pharmacies, Still Bullish On AmerisourceBergen And McKesson
C.R. Bard (BCR) Q1 Earnings, Sales Top; Currency Woes Stay - Analyst Blog (Zacks)

In a report published Thursday, Credit Suisse analyst Glen Santangelo reiterated an Outperform rating on AmerisourceBergen Corp. (NYSE: ABC), and raised the price target from $61.00 to $64.00.

In the report, Credit Suisse noted, “Despite the significant move in the shares YTD (~+31%), we continue to believe that ABC remains an attractive investment given the multi-year growth outlook created by the cumulative benefit of the WAG relationship. We believe investors have been too myopically focused on the $0.25 (gross) accretion contribution in F14 and are failing to fully appreciate the bigger (multi-year) picture, which has created a competitive advantage for ABC.”

AmerisourceBergen Corp. closed on Wednesday at $56.55.

Latest Ratings for ABC

DateFirmActionFromTo
Mar 2015UBSUpgradesNeutralBuy
Jan 2015Credit SuisseMaintainsOutperform
Jan 2015JP MorganMaintainsNeutral

View More Analyst Ratings for ABC
View the Latest Analyst Ratings

Posted-In: Credit Suisse Glen SantangeloAnalyst Color Price Target Analyst Ratings

 

Related Articles (ABC)

Around the Web, We're Loving...